2QE Stock Overview
Operates as a medtech company in Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
2cureX AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.17 |
| 52 Week High | SEK 0.20 |
| 52 Week Low | SEK 0.013 |
| Beta | 1.02 |
| 1 Month Change | 307.89% |
| 3 Month Change | 460.86% |
| 1 Year Change | 735.78% |
| 3 Year Change | -84.18% |
| 5 Year Change | -85.97% |
| Change since IPO | -83.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2QE | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 6.9% | 1.2% | 0.5% |
| 1Y | 735.8% | -9.0% | 14.4% |
Return vs Industry: 2QE exceeded the German Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: 2QE exceeded the German Market which returned 14.6% over the past year.
Price Volatility
| 2QE volatility | |
|---|---|
| 2QE Average Weekly Movement | 126.4% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 2QE's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2QE's weekly volatility has increased from 66% to 126% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 14 | Dan Honeywell | www.2curex.com |
2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers.
2cureX AB (publ) Fundamentals Summary
| 2QE fundamental statistics | |
|---|---|
| Market cap | €3.98m |
| Earnings (TTM) | -€2.41m |
| Revenue (TTM) | €181.01k |
22.0x
P/S Ratio-1.6x
P/E RatioIs 2QE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2QE income statement (TTM) | |
|---|---|
| Revenue | SEK 1.98m |
| Cost of Revenue | SEK 9.61m |
| Gross Profit | -SEK 7.63m |
| Other Expenses | SEK 18.72m |
| Earnings | -SEK 26.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Aug 21, 2025
| Earnings per share (EPS) | -1.05 |
| Gross Margin | -386.18% |
| Net Profit Margin | -1,333.30% |
| Debt/Equity Ratio | 0% |
How did 2QE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 16:50 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
2cureX AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oscar Bergman | Redeye |